Publications

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.

Drolet, M; Laprise, J-F; Martin, D; JIT, M; Bénard, É; Gingras, G; Boily, M-C; Alary, M; Baussano, I; Hutubessy, R; Brisson, M;

2021

The Lancet. Infectious diseases, (2021).21 11 10.1016/S1473-3099(20)30860-4.

Simulation results for "COVID-19 vaccination in Sindh Province, Pakistan: a modelling study of health impact and cost-effectiveness".

PEARSON, CA B; BOZZANI, F; PROCTER, SR; DAVIES, NG; Huda, M; JENSEN, HT; KEOGH-BROWN, M; Khalid, M; SWEENEY, S; TORRES-RUEDA, S; EGGO, RM; VASSALL, A; JIT, M;

2021

, Zenodo (2021).

The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across eleven distribution models in South Africa.

SANDE, L; Matsimela, K; Mostert, C; D'Elbee, M; Majam, M; Phiri, J; Zishiri, V; Madondo, C; Khama, S; Hatzold, K; Johnson, C; Chidarikire, T; TERRIS-PRESTHOLT, F; Meyer-Rath, G;

2021

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, (2021).24,

Get Tested LeEDs: Clinical impact and cost-effectiveness of opt-out emergency department testing for bloodborne viruses (BBVs).

Smout, E; WILLIAMS, J; Miners, A; Phyu, K; Parker, L; Evans, A; McLaren, J; Aldersley, M; Hughes, G; Ruf, M; Page, E;

2021

JOURNAL OF HEPATOLOGY, (2021).75,

Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review.

SAADI, N; Chi, Y-L; Ghosh, S; EGGO, RM; MCCARTHY, C; QUAIFE, M; Dawa, J; JIT, M; VASSALL, A;

2021

medRxiv (2021). 10.1101/2021.06.21.21259104.

Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis.

SANDMANN, F; JIT, M; Andrews, N; Buckley, HL; Campbell, H; Ribeiro, S; Sile, B; Stowe, J; Tessier, E; Ramsay, M; Amirthalingam, G; Choi, YH;

2021

Vaccine, (2021).39 32 10.1016/j.vaccine.2021.06.042.

Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.

Gaythorpe, KA; ABBAS, K; Huber, J; Karachaliou, A; Thakkar, N; Woodruff, K; Li, X; Echeverria-Londono, S; VIMC Working Group on COVID-19 Impact on Vaccine P,; Ferrari, M; Jackson, ML; McCarthy, K; Perkins, TA; Trotter, C; JIT, M;

2021

eLife, (2021).10, 10.7554/eLife.67023.

Barry, LE; O'NEILL, S; Heaney, LG; O'Neill, C;

2021

Social Science & Medicine, (2021).283, 10.1016/j.socscimed.2021.114170.

Optimising health and economic impacts of COVID-19 vaccine rollout strategies in the WHO European Region.

LIU, Y; Sandmann, FG; BARNARD, RC; PEARSON, CA B; CMMID Working-19 Working Group,; Pastore, R; Pebody, R; FLASCHE, S; JIT, M;

2021

, Zenodo (2021).

The impact of improved water supply on cholera and diarrhoeal diseases in Uvira, Democratic Republic of the Congo: a protocol for a pragmatic stepped-wedge cluster randomised trial and economic evaluation.

GALLANDAT, K; Jeandron, A; ROSS, I; Mufitini Saidi, J; Bashige Rumedeka, B; Lumami Kapepula, V; COUSENS, S; ALLEN, E; MACDOUGALL, A; CUMMING, O;

2021